Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rockville, MD
NPI
1114044906
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2401 Research Blvd, 230
Rockville, MD, 20850
Phone (301) 977-9272
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.2M
2,377 prescriptions
Company payments, 2025
$29K
From 5 companies
Medicare prescription drug claims, 2024
In 2024, the drug David R Brown prescribed most often to Medicare patients was Ezetimibe, with 215 prescriptions and refills. In total David R Brown wrote 2,377 Medicare prescriptions that cost $3.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ezetimibe Generic | 215 | 641 | 68 | $10K |
| Rosuvastatin Calcium Generic | 184 | 546 | 55 | $5,613 |
| Levothyroxine Sodium Generic | 147 | 430 | 34 | $1,994 |
| Synthroid Levothyroxine Sodium | 114 | 326 | 21 | $7,543 |
| Atorvastatin Calcium Generic | 110 | 319 | 37 | $1,568 |
| Ozempic Semaglutide | 109 | 209 | 24 | $186K |
| Mounjaro Tirzepatide | 76 | 118 | 18 | $119K |
| Metformin Hcl Er Metformin Hcl | 70 | 209 | 19 | $1,588 |
| Korlym Mifepristone | 59 | 59 | Under 11 | $2.3M |
| Tresiba Flextouch U-100 Insulin Degludec | 47 | 129 | 21 | $32K |
| Amlodipine Besylate Generic | 45 | 127 | 12 | $258 |
| Vascepa Icosapent Ethyl | 42 | 106 | Under 11 | $35K |
| Metformin Hcl Generic | 39 | 109 | 11 | $219 |
| Lisinopril Generic | 38 | 106 | Under 11 | $418 |
| Repatha Sureclick Evolocumab | 35 | 92 | Under 11 | $53K |
Brand drugs: 858 claims; generic drugs: 1,454 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David R Brown $29K ($29K in general payments such as food, travel and fees) from 5 companies. The largest payer was Corcept Therapeutics with $28K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.